- Home
- XERS vs PWP Comparison
XERS vs PWP Comparison
Compare XERS & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- PWP
- Stock Information
- Founded
- XERS 2005
- PWP 2006
- Country
- XERS United States
- PWP United States
- Employees
- XERS N/A
- PWP N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- PWP Finance: Consumer Services
- Sector
- XERS Health Care
- PWP Finance
- Exchange
- XERS Nasdaq
- PWP Nasdaq
- Market Cap
- XERS 1.3B
- PWP 1.3B
- IPO Year
- XERS 2018
- PWP N/A
- Fundamental
- Price
- XERS $7.36
- PWP $22.06
- Analyst Decision
- XERS Strong Buy
- PWP Hold
- Analyst Count
- XERS 7
- PWP 3
- Target Price
- XERS $8.00
- PWP $23.67
- AVG Volume (30 Days)
- XERS 1.9M
- PWP 1.1M
- Earning Date
- XERS 11-07-2025
- PWP 11-07-2025
- Dividend Yield
- XERS N/A
- PWP 1.27%
- EPS Growth
- XERS N/A
- PWP N/A
- EPS
- XERS N/A
- PWP 0.90
- Revenue
- XERS $246,025,000.00
- PWP $871,012,000.00
- Revenue This Year
- XERS $43.89
- PWP $1.99
- Revenue Next Year
- XERS $20.40
- PWP $25.18
- P/E Ratio
- XERS N/A
- PWP $24.48
- Revenue Growth
- XERS 35.62
- PWP 20.01
- 52 Week Low
- XERS $2.69
- PWP $14.12
- 52 Week High
- XERS $8.03
- PWP $27.03
- Technical
- Relative Strength Index (RSI)
- XERS 51.35
- PWP 52.41
- Support Level
- XERS $7.56
- PWP $21.67
- Resistance Level
- XERS $7.89
- PWP $22.75
- Average True Range (ATR)
- XERS 0.24
- PWP 0.88
- MACD
- XERS -0.14
- PWP -0.03
- Stochastic Oscillator
- XERS 2.90
- PWP 62.86
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About PWP Perella Weinberg Partners
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.